- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02119000
Comparison of Two Types of Bowel Preparation for Inpatient Colonoscopy
Bowel preparation is a crucial step prior to colonoscopy to help with the optimal assessment of the colonic mucosa. Inadequate bowel preparation increases the length of the procedure, and is associated with decreased lesional detection rates. The ideal bowel preparation formulation should be able to completely clean the bowel, without leaving solid or liquid residues, and without modifying the mucosal appearance.
Bowel preparation may be administered in hospitalised patients or in the ER. Patients have less control on their environment and the intake of the bowel preparation. For example, there may be a delay in pharmacy delivery or inadequate supervision by the treating personnel. Hospitalised patients have more comorbidities, are usually less autonomous and mobile - both can add to the barriers leading to an adequate bowel preparation. Multiple studies have identified hospitalization status as an independent risk factor for poor bowel preparation.
The objective of this study is to access which bowel preparation regimen, between PEG 3350 with electrolytes 2L the day before and 2L the day of the colonoscopy vs bisacodyl + PEG 3350 with electrolytes 1L the day before and 1L the day of the colonoscopy, results in the cleanest bowel preparation in hospitalised patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3G1A4
- McGill University Health Centre
-
Sherbrooke, Quebec, Canada, J1G 2E8
- Centre Hospitalier Universitaire de Sherbrooke
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- 18 years or older
- Be able to comprehend the trial and provide written informed consent in French or English, or a close relative with power of attorney
- Have a recognised indication for full colonoscopy after evaluation by a gastroenterologist or surgeon
- Be hospitalized or in the ED of a participating hospital center.
- Need to receive a bowel preparation during hospitalization or the ED stay.
- Be able to complete the follow-up patient response form in French or English
Exclusion Criteria:
- Patient refusal
- A suspected or diagnosed bowel obstruction
- A toxic megacolon
- Ileus
- Decompensated heart failure
- Severe acute renal failure
- Severe electrolyte imbalance
- Previous bowel preparation in the last 7 days
- Pregnancy
- Time of randomization before 9h00 or after 22h00
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PEG electrolytes 2L/2L split dose
|
Polyethylene glycol 17gm X 4 At 18h00 the day prior the colonoscopy, dilute 2 sachets in 2 L of water and drink 240 mL every 10 minutes On the day of the procedure, 4-5 hours prior the colonoscopy, dilute 2 sachets in 2 L of water and drink 240 mL every 10 minutes
|
Active Comparator: Bisacodyl 15 mg and PEG/electrolytes 1L/1L split dose
|
Bisacodyl 15 mg x 3 At 14h00 the day prior the endoscopic procedure: take 3 tablets of Bisacodyl ER (15 mg) orally then 5 hr later: PEG/electrolytes 1L/1L Polyethylene glycol 17gm Dilute one sachet of Polyethylene glycol 17gm in 1 L of water Start drinking at around 19h00 the night prior the colonoscopy Drink 240 ml every 10 minutes The day of the colonoscopy. At (4 hrs prior the procedure). Dilute on sachet of PEG and drink 240 ml every 10 minutes |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy
Time Frame: following colonoscopy
|
Which bowel preparation regimen, between PEG 3350 with electrolytes 2L the day before and 2L the day of the colonoscopy vs bisacodyl + PEG 3350 with electrolytes 1L the day before and 1L the day of the colonoscopy, results in the cleanest bowel preparation in hospitalised patients.
|
following colonoscopy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tolerability
Time Frame: Before colonoscopy
|
A questionnaire will be used to assess which is the most tolerable and acceptable to patients between the two bowel preparation regimens
|
Before colonoscopy
|
Clinical quality standards
Time Frame: After colonoscopy
|
Does the bowel preparation given prior to in-hospital colonoscopy result in an excellent or good preparation rate that falls within the required clinical quality standards?
|
After colonoscopy
|
Cecal/ileal intubation rate
Time Frame: Following colonoscopy
|
What is the cecal/ileal intubation rate for colonoscopies performed in hospitalized patients?
|
Following colonoscopy
|
Polyp detection rate
Time Frame: Following colonosopy
|
What is the polyp detection rate for colonoscopies performed in hospitalized patients?
|
Following colonosopy
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GEN 13-148
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hospitalized Patients
-
First People's Hospital of HangzhouHangzhou Cancer Hospital; First People's Hospital of Lin'an District; First People...RecruitingHospitalized PatientsChina
-
Mayo ClinicCompletedHospitalized PatientsUnited States
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research InstituteCompleted
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research InstituteCompleted
-
Copenhagen University Hospital, HvidovreCompletedHospitalized Older Medical PatientsDenmark
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedColonoscopy | Bowel Preparation | Hospitalized PatientsItaly
-
Hospices Civils de LyonUnknown
-
China Medical University HospitalUnknownSurgical Patients | Hospitalized PatientsTaiwan
-
Association Pour le Recherche en Infectiologie...Pr Bruno FantinCompletedColonization | Hospitalized Patients | Multi Drug Resistant BacteriaFrance
-
Helse Møre og Romsdal HFNorwegian University of Science and Technology; Sykehuset Innlandet HFCompletedAccidental Falls | Hospitalized PatientsNorway
Clinical Trials on PEG/electrolytes 2L/2L split dose
-
University of CalgaryUnknownColorectal CancerCanada
-
Air Force Military Medical University, ChinaCompleted
-
Pharmbio Korea Co., Ltd.Not yet recruitingIntestinal Disease | Colonic Disease
-
Promefarm S.r.l.Completed
-
Changhai HospitalTongji Hospital; Qilu Hospital of Shandong University; First Affiliated Hospital... and other collaboratorsCompletedAdenoma Detection Rate | Bowel Preparation Scale | the Amount of Air BubbleChina
-
Shandong UniversityUnknownColonoscopy | Bowel PreparationChina
-
Shandong UniversityQianfoshan Hospital; Binzhou People's HospitalCompleted
-
Ningbo No. 1 HospitalUnknown
-
Shandong UniversityUnknown
-
Kyungpook National University HospitalCompletedBowel Preparation QualityKorea, Republic of